Characterization, Cytotoxicity and Anti-Inflammatory Effect Evaluation of Nanocapsules Containing Nicotine

(1) Background: Nanotechnology is an emerging field that can be applied in the biomedical area. In this study, Eudragit nanocapsules (NCs) containing nicotine were produced. Nicotine is the main alkaloid found in tobacco and has anti-inflammatory properties. NCs containing nicotine may be used as an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carolina Landau Albrecht, Laura Elena Sperling, Daikelly Iglesias Braghirolli, Patricia Pranke
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
T
Acceso en línea:https://doaj.org/article/68e5f1eb34c04d568e9b32526ae78372
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:68e5f1eb34c04d568e9b32526ae78372
record_format dspace
spelling oai:doaj.org-article:68e5f1eb34c04d568e9b32526ae783722021-11-25T16:46:33ZCharacterization, Cytotoxicity and Anti-Inflammatory Effect Evaluation of Nanocapsules Containing Nicotine10.3390/bioengineering81101722306-5354https://doaj.org/article/68e5f1eb34c04d568e9b32526ae783722021-11-01T00:00:00Zhttps://www.mdpi.com/2306-5354/8/11/172https://doaj.org/toc/2306-5354(1) Background: Nanotechnology is an emerging field that can be applied in the biomedical area. In this study, Eudragit nanocapsules (NCs) containing nicotine were produced. Nicotine is the main alkaloid found in tobacco and has anti-inflammatory properties. NCs containing nicotine may be used as an adjuvant therapy in the treatment of inflammation in the central nervous system. (2) Methods: Nanocapsules were prepared by the interfacial deposition of the pre-formed polymer method and characterized in terms of zeta potential, diameter, polydispersity index, pH, encapsulation efficiency (EE), stability and sustained release profile. In vitro tests with the PC12 cell line were performed, such as MTT, LIVE/DEAD and ELISA assays, to verify their cytotoxic and anti-inflammatory effects. (3) Results: The nanocapsules presented satisfactory values of the characterization parameters; however, poor encapsulation was obtained for nicotine (8.17% ± 0.47). The in vitro tests showed that the treatment with nanocapsules reduced cell viability, which suggests that the Eudragit or the amount of polymer on top of the cells may be detrimental to them, as the cells were able to survive when treated with bulk nicotine. ELISA showed an increment in the expression of IL-6 and IL-1β, corroborating the hypothesis that NCs were toxic to the cells because of the increase in the levels of these pro-inflammatory cytokines. (4) Conclusions: This study demonstrates that NCs of Eudragit present toxicity. It is therefore necessary to improve NC formulation to obtain better values for the encapsulation efficiency and reduce toxicity of these nanodevices.Carolina Landau AlbrechtLaura Elena SperlingDaikelly Iglesias BraghirolliPatricia PrankeMDPI AGarticlenanocapsulesEudragitnicotineinflammationPC12TechnologyTBiology (General)QH301-705.5ENBioengineering, Vol 8, Iss 172, p 172 (2021)
institution DOAJ
collection DOAJ
language EN
topic nanocapsules
Eudragit
nicotine
inflammation
PC12
Technology
T
Biology (General)
QH301-705.5
spellingShingle nanocapsules
Eudragit
nicotine
inflammation
PC12
Technology
T
Biology (General)
QH301-705.5
Carolina Landau Albrecht
Laura Elena Sperling
Daikelly Iglesias Braghirolli
Patricia Pranke
Characterization, Cytotoxicity and Anti-Inflammatory Effect Evaluation of Nanocapsules Containing Nicotine
description (1) Background: Nanotechnology is an emerging field that can be applied in the biomedical area. In this study, Eudragit nanocapsules (NCs) containing nicotine were produced. Nicotine is the main alkaloid found in tobacco and has anti-inflammatory properties. NCs containing nicotine may be used as an adjuvant therapy in the treatment of inflammation in the central nervous system. (2) Methods: Nanocapsules were prepared by the interfacial deposition of the pre-formed polymer method and characterized in terms of zeta potential, diameter, polydispersity index, pH, encapsulation efficiency (EE), stability and sustained release profile. In vitro tests with the PC12 cell line were performed, such as MTT, LIVE/DEAD and ELISA assays, to verify their cytotoxic and anti-inflammatory effects. (3) Results: The nanocapsules presented satisfactory values of the characterization parameters; however, poor encapsulation was obtained for nicotine (8.17% ± 0.47). The in vitro tests showed that the treatment with nanocapsules reduced cell viability, which suggests that the Eudragit or the amount of polymer on top of the cells may be detrimental to them, as the cells were able to survive when treated with bulk nicotine. ELISA showed an increment in the expression of IL-6 and IL-1β, corroborating the hypothesis that NCs were toxic to the cells because of the increase in the levels of these pro-inflammatory cytokines. (4) Conclusions: This study demonstrates that NCs of Eudragit present toxicity. It is therefore necessary to improve NC formulation to obtain better values for the encapsulation efficiency and reduce toxicity of these nanodevices.
format article
author Carolina Landau Albrecht
Laura Elena Sperling
Daikelly Iglesias Braghirolli
Patricia Pranke
author_facet Carolina Landau Albrecht
Laura Elena Sperling
Daikelly Iglesias Braghirolli
Patricia Pranke
author_sort Carolina Landau Albrecht
title Characterization, Cytotoxicity and Anti-Inflammatory Effect Evaluation of Nanocapsules Containing Nicotine
title_short Characterization, Cytotoxicity and Anti-Inflammatory Effect Evaluation of Nanocapsules Containing Nicotine
title_full Characterization, Cytotoxicity and Anti-Inflammatory Effect Evaluation of Nanocapsules Containing Nicotine
title_fullStr Characterization, Cytotoxicity and Anti-Inflammatory Effect Evaluation of Nanocapsules Containing Nicotine
title_full_unstemmed Characterization, Cytotoxicity and Anti-Inflammatory Effect Evaluation of Nanocapsules Containing Nicotine
title_sort characterization, cytotoxicity and anti-inflammatory effect evaluation of nanocapsules containing nicotine
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/68e5f1eb34c04d568e9b32526ae78372
work_keys_str_mv AT carolinalandaualbrecht characterizationcytotoxicityandantiinflammatoryeffectevaluationofnanocapsulescontainingnicotine
AT lauraelenasperling characterizationcytotoxicityandantiinflammatoryeffectevaluationofnanocapsulescontainingnicotine
AT daikellyiglesiasbraghirolli characterizationcytotoxicityandantiinflammatoryeffectevaluationofnanocapsulescontainingnicotine
AT patriciapranke characterizationcytotoxicityandantiinflammatoryeffectevaluationofnanocapsulescontainingnicotine
_version_ 1718412959735087104